Detalhe da pesquisa
1.
Prevalence and Financial Burden of Digestive Diseases in a Commercially Insured Population.
Clin Gastroenterol Hepatol
; 20(7): 1480-1487.e7, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217877
2.
Mass Balance and Drug Interaction Potential of Intravenous Eravacycline Administered to Healthy Subjects.
Antimicrob Agents Chemother
; 63(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559132
3.
Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30150464
4.
Efficacy and Tolerability of Eravacycline in Bacteremic Patients with Complicated Intra-Abdominal Infection: A Pooled Analysis from the IGNITE1 and IGNITE4 Studies.
Surg Infect (Larchmt)
; 22(5): 556-561, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33201771
5.
An Evaluation of Treatment Patterns and Associated Outcomes Among Adult Hospitalized Patients With Lower-Risk Community-Acquired Complicated Intra-abdominal Infections: How Often Are Expert Guidelines Followed?
Open Forum Infect Dis
; 7(7): ofaa237, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676511
6.
Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials.
Open Forum Infect Dis
; 7(12): ofaa548, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33365356
7.
Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance.
Future Microbiol
; 14: 1293-1308, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570004